These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3334188)

  • 41. Night-time rioprostil versus ranitidine in duodenal ulcer healing.
    Dammann HG; Walter TA; Müller P; Simon B
    Lancet; 1986 Aug; 2(8502):335-6. PubMed ID: 2874339
    [No Abstract]   [Full Text] [Related]  

  • 42. Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori-positive functional dyspepsia.
    Schütze K; Hentschel E; Hirschl AM
    Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):41-6. PubMed ID: 8900907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Non-ulcer dyspepsia].
    Shiina Y; Hasebe T; Harasawa S
    Nihon Rinsho; 1991 Feb; 49(2):479-87. PubMed ID: 2010953
    [No Abstract]   [Full Text] [Related]  

  • 44. [Types of duodenal ulcer according to antrum function: its relation to the gastric acid secretory capacity and blood group. Therapeutic implication].
    Gutiérrez Cabano CA
    Acta Gastroenterol Latinoam; 1982; 12(1):11-21. PubMed ID: 7136452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
    Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
    Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomised double blind placebo controlled clinical trial of sucralfate and ranitidine in chronic duodenal ulcer.
    Nair KV; Ramachandran TM; Thomas V; Rajindranath T
    J Assoc Physicians India; 1990 Mar; 38(3):211-2. PubMed ID: 2202705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ranitidine in the treatment of non-steroidal anti-inflammatory agent-induced damage of the stomach and duodenal mucosa. Results of a randomized, placebo-controlled double-blind study in patients with rheumatic diseases].
    Simon B; Beckers KH; Biewer W; Bouzo MH; Dammann HG; Gebest HJ; Müller P; Schütz E
    Z Gastroenterol; 1988 Jun; 26(6):310-3. PubMed ID: 3061183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial.
    Rösch W
    Scand J Gastroenterol; 1987 Mar; 22(2):161-4. PubMed ID: 3554491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Do non-steroidal anti-inflammatory drugs cause duodenal ulcer? Evaluation of basal acid output and ulcer complications.
    Collen MJ; Abdulian JD
    J Gastroenterol Hepatol; 1996 Jun; 11(6):520-3. PubMed ID: 8792303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group.
    Blum AL; Arnold R; Stolte M; Fischer M; Koelz HR
    Gut; 2000 Oct; 47(4):473-80. PubMed ID: 10986206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of duodenal ulcer relapse with ranitidine.
    Mekel RC; den Boer DJ
    S Afr Med J; 1985 Sep; 68(6):385-6. PubMed ID: 3898417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rioprostil vs. ranitidine in duodenal ulcer healing: a double-blind multicentre trial.
    Lavignolle A; Raillat A; Slama JL; Viteau JM; Veyres B; Lebourgeois P; Audigier JC; Abgrall J; Parlier H; Vray M
    Scand J Gastroenterol Suppl; 1989; 164():194-7. PubMed ID: 2510267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eradication of Helicobacter pylori infection in patients with non-ulcer dyspepsia. Effects on basal and bombesin-stimulated serum gastrin and gastric acid secretion.
    Verhulst ML; Hopman WP; Tangerman A; Jansen JB
    Scand J Gastroenterol; 1995 Oct; 30(10):968-73. PubMed ID: 8545617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies of basal and stimulated gastric acid output in Jordanian male and female patients and controls.
    Toukan AU; Arnaout MA; Abu-Romiyeh AS
    Trop Geogr Med; 1985 Mar; 37(1):56-61. PubMed ID: 4012852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine?
    Farup PG; Hovde O; Breder O
    Scand J Gastroenterol; 1995 Sep; 30(9):829-32. PubMed ID: 8578179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acid secretory changes and early relapse following duodenal ulcer healing with ranitidine or sucralfate.
    Marks IN; Johnston DA; Young GO
    Am J Med; 1991 Aug; 91(2A):95S-101S. PubMed ID: 1882911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indications for treatment of Helicobacter pylori infection: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Twenty-four-hour intragastric pH-metry: H2-receptor antagonist restoration of nightly gastric spontaneous alkalinization in duodenal ulcer healing.
    Bianco A; Cagossi M; Piraccini R; Greco AV
    Riv Eur Sci Med Farmacol; 1992; 14(5):281-91. PubMed ID: 1364062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastric acid secretory response in Helicobacter pylori-positive patients with duodenal ulcer disease.
    Jacobson K; Chiba N; Chen Y; Barrientos M; James C; Riddell RH; Hunt RH
    Can J Gastroenterol; 2001 Jan; 15(1):29-39. PubMed ID: 11173324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastric acid secretion studies in Enugu, using pentagastrin stimulation.
    Orjioke CJ; Ukabam SO
    Scand J Gastroenterol Suppl; 1986; 124():71-4. PubMed ID: 3508646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.